AstraZeneca takes another step forwards towards its target of growing revenues to $80bn by 2030, as quarterly sales top $15bn for the first time.

Shortly after reporting weaker sales growth for its injectable GLP-1 drugs, Novo Nordisk has new data to help it stake a claim to the oral

China will reverse its ban on importing DNA sequencers from Illumina, the company confirmed on Wednesday, potentially marking a renewed business opportunity in a key

Pfizer’s chances of becoming an obesity drug contender just hit a major snag. A Delaware Chancery judge on Wednesday afternoon denied Pfizer’s request for a

The government is back in court to defend its plan to limit spending on overhead research costs for NIH grantees. The US Court of Appeals